
Kigali, Rwanda — Rwanda is once again positioning itself at the forefront of healthcare innovation as it prepares to host Genomic Frontiers: Rwanda 2025, a high-level symposium bringing together leading scientists, policymakers, and innovators to explore how genomics can transform health systems across Africa.
The three-day conference, organized by Goodlife Access, will convene experts from Africa and around the world to discuss how genomic science can power the next generation of healthcare — from disease surveillance and personalized medicine to health financing and education.
Rwanda: Turning Vision into Action
Known for its ability to translate ambition into measurable progress, Rwanda has long been a model for innovation-driven public health.
From deploying the world’s first national drone delivery network to establishing a data-based healthcare system, the country has consistently shown how technology can improve access and equity.
With genomics now emerging as a frontier in medicine, Rwanda is extending that legacy into personalized healthcare — envisioning a future where genomic insights guide everyday clinical decisions, even at the pharmacy counter.
Science Meets Policy and Practice:

The symposium’s sessions will cover a range of themes, including:
Genomic tools: Developing advanced systems for disease surveillance, prevention, diagnosis, and treatment, drawing lessons from the 2024 Marburg virus outbreak.
Women’s health: Investigating the connections between reproductive health and overall well-being.
Health financing: Exploring sustainable models to integrate genomic technologies into public health systems.
Education: Building and retaining genomic research and clinical capacity within Rwanda.
A Platform for African Leadership:
The event also highlights Africa’s growing influence in the global genomics arena.
Through investments in infrastructure, research, and training, Rwanda and its partners are shaping a continental model for using genomics to strengthen public health and deliver precision care.
“This is more than a scientific meeting — it’s a pivotal moment,” said Jean-Baptiste Mazarati, Board Chair of Goodlife Access.
“Rwanda’s track record proves that innovation doesn’t just happen elsewhere. It happens here, through vision, collaboration, and a commitment to improving lives in every community.”

Goodlife Genomics, a program of Goodlife Access, is dedicated to advancing genomic research, data science, and precision healthcare in Africa. Through collaboration and education, it aims to make cutting-edge science both accessible and impactful across the continent.